The Defense Health Agency awarded a $619,500 Project Grant to the Sloan-Kettering Institute for Cancer Research, a non-profit organization in New York, NY. The grant is funded through the Military Medical Research and Development (CFDA 12.420) program and will support research to investigate the immunogenicity and targeting of shared neoantigens in adenoid cystic cancer over a 3-year period from September 1, 2023 to August 31, 2026. The research aims to transform health care for Service Members and the American public through innovative and impactful cancer research. As a non-profit research institution, Sloan-Kettering Institute has extensive experience conducting federally-funded biomedical research related to cancer biology, diagnostics, and therapeutics, often serving as a prime grantee or subawardee on projects with universities and other research partners.
Generated 4/9/24, 7:15 AM